Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) EBT Margin (2016 - 2026)

Angiodynamics' EBT Margin history spans 17 years, with the latest figure at 10.29% for Q1 2026.

  • For Q1 2026, EBT Margin fell 417.0% year-over-year to 10.29%; the TTM value through Feb 2026 reached 10.0%, up 485.0%, while the annual FY2025 figure was 11.63%, 5142.0% up from the prior year.
  • EBT Margin reached 10.29% in Q1 2026 per ANGO's latest filing, down from 8.0% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 44.31% in Q3 2023 to a low of 265.68% in Q1 2024.
  • Average EBT Margin over 5 years is 24.49%, with a median of 11.97% recorded in 2023.
  • Peak YoY movement for EBT Margin: crashed -25370bps in 2024, then surged 25955bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 10.59% in 2022, then tumbled by -51bps to 15.96% in 2023, then increased by 7bps to 14.89% in 2024, then skyrocketed by 46bps to 8.0% in 2025, then fell by -29bps to 10.29% in 2026.
  • Per Business Quant, the three most recent readings for ANGO's EBT Margin are 10.29% (Q1 2026), 8.0% (Q4 2025), and 14.31% (Q3 2025).